390 related articles for article (PubMed ID: 32410512)
61. Postbiotics and paraprobiotics: From concepts to applications.
Cuevas-González PF; Liceaga AM; Aguilar-Toalá JE
Food Res Int; 2020 Oct; 136():109502. PubMed ID: 32846581
[TBL] [Abstract][Full Text] [Related]
62. Postbiotics in Human Health: A Narrative Review.
Ma L; Tu H; Chen T
Nutrients; 2023 Jan; 15(2):. PubMed ID: 36678162
[TBL] [Abstract][Full Text] [Related]
63. Comparative Studies of Inhibitory and Antioxidant Activities, and Organic Acids Compositions of Postbiotics Produced by Probiotic
Chang HM; Foo HL; Loh TC; Lim ETC; Abdul Mutalib NE
Front Vet Sci; 2020; 7():602280. PubMed ID: 33575277
[TBL] [Abstract][Full Text] [Related]
64. Bidirectional effects of intestinal microbiota and antibiotics: a new strategy for colorectal cancer treatment and prevention.
Zhang W; Zhang J; Liu T; Xing J; Zhang H; Wang D; Tang D
J Cancer Res Clin Oncol; 2022 Sep; 148(9):2387-2404. PubMed ID: 35661254
[TBL] [Abstract][Full Text] [Related]
65. Postbiotics as Metabolites and Their Biotherapeutic Potential.
Hijová E
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791478
[TBL] [Abstract][Full Text] [Related]
66. Interplay between diet, gut microbiota, epigenetic events, and colorectal cancer.
Bultman SJ
Mol Nutr Food Res; 2017 Jan; 61(1):. PubMed ID: 27138454
[TBL] [Abstract][Full Text] [Related]
67. Intestinal microbiota and colorectal cancer: a new aspect of research.
Koliarakis I; Psaroulaki A; Nikolouzakis TK; Kokkinakis M; Sgantzos MN; Goulielmos G; Androutsopoulos VP; Tsatsakis A; Tsiaoussis J
J BUON; 2018; 23(5):1216-1234. PubMed ID: 30512251
[TBL] [Abstract][Full Text] [Related]
68. Probiotics in colorectal cancer (CRC) with emphasis on mechanisms of action and current perspectives.
Kahouli I; Tomaro-Duchesneau C; Prakash S
J Med Microbiol; 2013 Aug; 62(Pt 8):1107-1123. PubMed ID: 23558140
[TBL] [Abstract][Full Text] [Related]
69. Impacts of foodborne inorganic nanoparticles on the gut microbiota-immune axis: potential consequences for host health.
Lamas B; Martins Breyner N; Houdeau E
Part Fibre Toxicol; 2020 Jun; 17(1):19. PubMed ID: 32487227
[TBL] [Abstract][Full Text] [Related]
70. Probiotics, prebiotics and amelioration of diseases.
Tsai YL; Lin TL; Chang CJ; Wu TR; Lai WF; Lu CC; Lai HC
J Biomed Sci; 2019 Jan; 26(1):3. PubMed ID: 30609922
[TBL] [Abstract][Full Text] [Related]
71. Gut dysbiosis, leaky gut, and intestinal epithelial proliferation in neurological disorders: towards the development of a new therapeutic using amino acids, prebiotics, probiotics, and postbiotics.
Maguire M; Maguire G
Rev Neurosci; 2019 Jan; 30(2):179-201. PubMed ID: 30173208
[TBL] [Abstract][Full Text] [Related]
72. Bioengineered Colorectal Cancer Drugs: Orally Delivered Anti-Inflammatory Agents.
Urbanska AM; Zhang X; Prakash S
Cell Biochem Biophys; 2015 Jul; 72(3):757-69. PubMed ID: 27352189
[TBL] [Abstract][Full Text] [Related]
73. Study Insights into Gastrointestinal Cancer through the Gut Microbiota.
Kong F; Cai Y
Biomed Res Int; 2019; 2019():8721503. PubMed ID: 31341907
[TBL] [Abstract][Full Text] [Related]
74. Postbiotics, Metabolic Signaling, and Cancer.
Vrzáčková N; Ruml T; Zelenka J
Molecules; 2021 Mar; 26(6):. PubMed ID: 33799580
[TBL] [Abstract][Full Text] [Related]
75. Probiotics: A Promising Candidate for Management of Colorectal Cancer.
Tripathy A; Dash J; Kancharla S; Kolli P; Mahajan D; Senapati S; Jena MK
Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34202265
[TBL] [Abstract][Full Text] [Related]
76. Postbiotic production: harnessing the power of microbial metabolites for health applications.
Prajapati N; Patel J; Singh S; Yadav VK; Joshi C; Patani A; Prajapati D; Sahoo DK; Patel A
Front Microbiol; 2023; 14():1306192. PubMed ID: 38169918
[TBL] [Abstract][Full Text] [Related]
77. Postbiotics as the key mediators of the gut microbiota-host interactions.
Ozma MA; Abbasi A; Akrami S; Lahouty M; Shahbazi N; Ganbarov K; Pagliano P; Sabahi S; Köse Ş; Yousefi M; Dao S; Asgharzadeh M; Hosseini H; Kafil HS
Infez Med; 2022; 30(2):180-193. PubMed ID: 35693065
[TBL] [Abstract][Full Text] [Related]
78. Postbiotics Enhance NK Cell Activation in Stress-Induced Mice through Gut Microbiome Regulation.
Jung YJ; Kim HS; Jaygal G; Cho HR; Lee KB; Song IB; Kim JH; Kwak MS; Han KH; Bae MJ; Sung MH
J Microbiol Biotechnol; 2022 May; 32(5):612-620. PubMed ID: 35283424
[TBL] [Abstract][Full Text] [Related]
79. Gut health benefit and application of postbiotics in animal production.
Zhong Y; Wang S; Di H; Deng Z; Liu J; Wang H
J Anim Sci Biotechnol; 2022 Apr; 13(1):38. PubMed ID: 35392985
[TBL] [Abstract][Full Text] [Related]
80. Potential Use of Biotherapeutic Bacteria to Target Colorectal Cancer-Associated Taxa.
Lawrence GW; Begley M; Cotter PD; Guinane CM
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32019270
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
